Kneat Update in Light of COVID-19

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Kneat Update in Light of COVID-19

Canada NewsWire

LIMERICK, Ireland, March 24, 2020 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") update. COVID-19 is affecting each of us in various ways, and some segments of our society are being hit much harder than others.

Our thoughts are first and foremost with front-line workers who are tirelessly fighting the virus in our hospitals and in our communities.  They have rarely been challenged as they are now, and we owe them an enormous gratitude. We must help in any we can and maintain our focus on social distancing, isolation and hygiene.

At Kneat, the health and safety of our employees and the people we interact with is central to the decisions we are taking. The week before last we transitioned to remote working for all our employees. Our operations from software development through to product release, delivery and customer service are now securely online. We have stopped all business travel and every customer interaction is now online. We have postponed our 2020 customer summit and have cancelled attendance at all upcoming industry conferences.

From discussions within our market, we expect a small proportion of companies may defer purchasing decisions in the short term, as they remain focused on business continuity activities. In general, it is business as usual for most companies, including those that have begun to deploy our software or are already using Kneat at their sites.

We are serving many of the world's largest pharmaceutical companies. At least four of our customers are targeting vaccines and treatments for COVID-19. Our technology is allowing them to manage aspects of their critical validation processes remotely, while eliminating the need to use and route paper. Several of our customers have told us how Kneat Gx is especially beneficial at this time, because it allows them to collaborate and manage their process in real time, without personnel having to travel or be in one location.

We are proud to be associated with this effort and of the contribution we are making. The benefits of using our software, and its relevance and utility within the pharmaceutical industry have never been so clear.

In early March, we raised $14.5 million to fund growth and expansion opportunities, while strengthening our balance sheet. This funding round was oversubscribed during a difficult time in the equity markets, a testament to confidence in Kneat. Kneat investors are excited about our technology and the solutions it provides.

Notwithstanding the current challenges that exist, we will continue to deliver high quality software and services for our customers.

Our thoughts are with you and especially front-line workers who are working tirelessly to save lives and fight this disease.

About Kneat

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx software platform. Multiple business work processes can be configured on the platform from equipment to computer system validation, through to quality document management. Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard.  For more information visit www.kneat.com

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes "forward-looking information" within the meaning of applicable Canadian securities laws.  Such forward-looking information, includes, but is not limited to, the relationship between Kneat and the customer, Kneat's business development activities, the use and implementation timelines of Kneat's software within the customer's validation processes, the ability and intent of the customer to scale the use of Kneat's software within the customer's organization and the compliance of Kneat's platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.  Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investors' own risk.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE kneat.com, inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2020/24/c7289.html

Copyright CNW Group 2020

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).